drugset

drugset / Trial / NCT06110923

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

NCT06110923 ↗

Phase 1 Completed 31 enrolled Chong Kun Dang Pharmaceutical

RandomizedParallel-groupOpen-labelTreatment

Summary

A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846

Timeline

Start: 2023-11-13
Primary completion: 2024-05-10
Completion: 2025-03-25

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-846	Unknown	—	—
Subject	D091	Unknown	—	—

Indications